These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19050056)

  • 21. Early skeletal and biochemical alterations in pediatric chronic kidney disease.
    Wesseling-Perry K; Pereira RC; Tseng CH; Elashoff R; Zaritsky JJ; Yadin O; Sahney S; Gales B; Jüppner H; Salusky IB
    Clin J Am Soc Nephrol; 2012 Jan; 7(1):146-52. PubMed ID: 22052943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of the new bone classification system in pediatric renal osteodystrophy.
    Bakkaloglu SA; Wesseling-Perry K; Pereira RC; Gales B; Wang HJ; Elashoff RM; Salusky IB
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1860-6. PubMed ID: 20634327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
    Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ
    PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
    JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H; Cui Y; Xing C; Purrunsing Y; Zha X; Shen C; Zeng M; Yang G; Yu X; Zhang L; Jiang Y; Shen Z; Ma H; Yin C; Li Y; Wang N
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone and mineral metabolism do not have significant impact on pulse pressure in patients undergoing peritoneal dialysis.
    Chow KM; Szeto CC; Li PK
    Clin Nephrol; 2003 Oct; 60(4):266-9. PubMed ID: 14579941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
    Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial.
    Bacchetta J; Wesseling-Perry K; Kuizon B; Pereira RC; Gales B; Wang HJ; Elashoff R; Salusky IB
    Clin J Am Soc Nephrol; 2013 May; 8(5):824-32. PubMed ID: 23559676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
    Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
    Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
    Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
    Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
    Seeherunvong W; Abitbol CL; Chandar J; Rusconi P; Zilleruelo GE; Freundlich M
    Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.
    Isakova T; Gutierrez O; Shah A; Castaldo L; Holmes J; Lee H; Wolf M
    J Am Soc Nephrol; 2008 Mar; 19(3):615-23. PubMed ID: 18216315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.
    Shimada T; Urakawa I; Isakova T; Yamazaki Y; Epstein M; Wesseling-Perry K; Wolf M; Salusky IB; Jüppner H
    J Clin Endocrinol Metab; 2010 Feb; 95(2):578-85. PubMed ID: 19965919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian variation of mineral and bone parameters in end-stage renal disease.
    Trivedi H; Szabo A; Zhao S; Cantor T; Raff H
    J Nephrol; 2015 Jun; 28(3):351-9. PubMed ID: 25138650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.
    Isakova T; Xie H; Barchi-Chung A; Vargas G; Sowden N; Houston J; Wahl P; Lundquist A; Epstein M; Smith K; Contreras G; Ortega L; Lenz O; Briones P; Egbert P; Ikizler TA; Jueppner H; Wolf M
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2688-95. PubMed ID: 21903990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.
    Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
    Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.